XML 67 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SCHEDULE I - ADDITIONAL INFORMATION OF THE PARENT COMPANY (Tables)
12 Months Ended
Dec. 31, 2023
SCHEDULE I - ADDITIONAL INFORMATION OF THE PARENT COMPANY  
Schedule of condensed balance sheets

As of December 31, 

2022

2023

    

RMB

    

RMB

    

US$

ASSETS

 

  

 

  

 

  

Current assets:

Cash and cash equivalents

 

3,574,342,723

 

4,116,400,819

 

579,782,929

Short-term deposits

 

1,741,150,000

 

1,416,540,000

 

199,515,486

Prepayments

 

253,238

 

197,803

 

27,860

Other current assets

 

65,929,085

 

154,904,218

 

21,817,803

Total current assets

 

5,381,675,046

 

5,688,042,840

 

801,144,078

Investments in subsidiaries and VIEs

 

1,222,310,375

 

1,048,858,412

 

147,728,617

Total assets

 

6,603,985,421

 

6,736,901,252

 

948,872,695

LIABILITIES

 

 

 

Current liabilities:

 

 

 

Accrued expenses and other current liabilities

 

23,376,040

 

39,095,925

 

5,506,546

Amounts due to subsidiaries and VIEs

 

338,595

 

344,337

 

48,499

Deferred revenue

 

13,141,069

 

8,128,004

 

1,144,805

Total current liabilities

 

36,855,704

 

47,568,266

 

6,699,850

Non-current liabilities

 

6,570,535

 

 

Total liabilities

 

43,426,239

 

47,568,266

 

6,699,850

Shareholders’ equity

 

 

 

Ordinary shares

 

23,336

 

23,336

 

3,287

Treasury shares

 

(911,217,013)

 

(911,217,013)

 

(128,342,232)

Additional paid-in capital

 

10,670,286,906

 

10,670,286,906

 

1,502,878,478

Accumulated deficit

 

(3,520,524,817)

 

(3,485,007,183)

 

(490,852,996)

Accumulated other comprehensive income

 

321,990,770

 

415,246,940

 

58,486,308

Total shareholders’ equity

 

6,560,559,182

 

6,689,332,986

 

942,172,845

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

6,603,985,421

 

6,736,901,252

 

948,872,695

Schedule of condensed statements of comprehensive loss

Years ended December 31, 

2021

2022

2023

    

RMB

    

RMB

    

RMB

    

US$

General and administrative expenses

 

(83,456,188)

 

(38,959,768)

 

(42,927,343)

 

(6,046,190)

Research and development expenses

 

(2,454,862)

 

 

 

Equity in loss of subsidiaries and share of loss from VIEs

 

(505,172,018)

 

(170,956,497)

 

(190,965,494)

 

(26,896,927)

Other operating (expense) income, net

 

(24,367,660)

 

42,792,705

 

19,838,460

 

2,794,189

Interest income

 

33,567,582

 

91,701,152

 

249,448,848

 

35,134,135

Foreign exchange gain, net

123,163

17,347

Net (loss) income

 

(581,883,146)

 

(75,422,408)

 

35,517,634

 

5,002,554

Other comprehensive (loss) income:

 

Foreign currency translation adjustment

 

(123,533,529)

 

434,612,446

 

93,256,170

 

13,134,857

Comprehensive (loss) income

 

(705,416,675)

 

359,190,038

 

128,773,804

 

18,137,411

Schedule of condensed statements of cash flows

Years ended December 31, 

2021

2022

2023

    

RMB

    

RMB

    

RMB

    

US$

CASH FLOWS FROM OPERATING ACTIVITIES

 

  

 

  

 

  

 

  

Net (loss) income

 

(581,883,146)

 

(75,422,408)

 

35,517,634

 

5,002,554

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

  

 

 

 

Equity in (income) loss of subsidiaries and share of income (loss) from VIEs

 

505,172,018

 

170,956,497

 

190,965,494

 

26,896,927

Share-based compensation

 

12,144,578

 

6,196,546

 

 

Foreign exchange gain or loss

(123,163)

(17,347)

Changes in operating assets and liabilities:

 

  

 

 

 

Prepayments

 

(10,586,501)

 

11,223,022

 

55,435

 

7,808

Other current assets

 

9,623,257

 

(51,285,121)

 

(88,851,970)

 

(12,514,537)

Amounts due from subsidiaries and VIEs

 

38,099,544

 

 

 

Accrued expenses and other current liabilities

 

38,682,365

 

(34,425,208)

 

15,719,885

 

2,214,099

Others

 

(13,015,215)

 

(10,363,176)

 

(11,583,600)

 

(1,631,516)

CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES

 

(1,763,100)

 

16,880,152

 

141,699,715

 

19,957,988

Proceeds from disposal of short-term investments

1,370,229,000

1,654,283,000

2,098,625,000

295,585,149

Purchases of short-term investments

 

(956,355,000)

 

(2,385,288,000)

 

(1,778,550,000)

 

(250,503,528)

Investment in subsidiaries

 

(424,558,504)

 

(181,739,530)

 

(16,196,850)

 

(2,281,279)

CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES

 

(10,684,504)

 

(912,744,530)

303,878,150

 

42,800,342

Repurchase of ordinary shares

 

(107,151,908)

 

(108,967,252)

 

 

CASH USED IN FINANCING ACTIVITIES

 

(107,151,908)

 

(108,967,252)

 

 

Effect of foreign exchange rate changes

 

(123,540,779)

 

372,915,098

 

96,480,231

 

13,588,956

NET DECREASE (INCREASE) IN CASH AND CASH EQUIVALENTS

 

(243,140,291)

 

(631,916,532)

 

542,058,096

 

76,347,286

CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR

 

4,449,399,546

 

4,206,259,255

 

3,574,342,723

 

503,435,643

CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR

 

4,206,259,255

 

3,574,342,723

 

4,116,400,819

 

579,782,929